JPRN-UMIN000011681已完成2 期
Phase II study of nab-paclitaxel and carboplatin with concurrent thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer - Phase II study of ABI + CBDCA + TRT for unresectable LA-NSCLC
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Active double cancer. 2)Active infections requiring systemic treatment. 3)Serious complications(e.g. heart failure, renal failure, hepatic failure, haemorrhagic peptic ulcer, intestinal paralysis, intestinal obstruction or poorly controlled diabetes) 4)Grade2 or higher peripheral neuropathy. 5)Positive HBs antigen and/or HCV antibody. 6)History of severe drug allergy. 7)History of hypersensivity for albumin-containing agents. 8)Pregnant females, possibly pregnant females, females wishing to become pregnant and nursing mothers.Males that are currently attempting to produce a pregnancy. 9)Judged ineligible by physicians for participation in the study from a safety viewpoint.
研究者
相似试验
招募中
2 期
Phase II Study of Nab-paclitaxel and Carboplatin Plus Bevacizumab as First-Line Chemotherapy for Reccurent or stage IIIB and IV Nonsquamous Non-Small-Cell Lung Cancer (ALCT004)on-squamous non-small-cell lung cancerJPRN-UMIN000013310Kyorin University School of Medicine33
招募中
1 期
Phase I/II study of carboplatin and nab-paclitaxel and concurrent thoracic radiation for patients with Locally advanced NSCLCJPRN-UMIN000020359Gunma University50
已完成
不适用
Phase II trial of nab-paclitaxel and carboplatin with concurrent radiotherapy for patients with locally advanced non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000019611Department of Radiation Oncology, Yamaguchi University Hospital37
已完成
2 期
Phase II study of Carboplatin plus nab-Paclitaxel for advanced non-small cell lung cancer patients with interstitial lung diseaseAdvanced non-small cell lung cancer with interstitial lung diseaseJPRN-UMIN000012989Kanagawa Cardiovascular and Respiratory Center90
招募中
1 期
PhaseI/II study of carboplatin plus nab-paclitaxel plus bevacizumab administered to advanced non-squamous non-small cell lung cancer.advanced non-squamous non-small cell lung cancerJPRN-UMIN000013333agoya City West Medical Center35